Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

1. Comparison of empiric versus whole-body/-blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer

   Journal Article

   Deandreis, D.; Rubino, C.; Tala, H.; Leboulleux, S.; Terroir, M.; Baudin, E.; Larson, S.; Fagin, J. A.; Schlumberger, M.; Tuttle, R. M.
   Journal of Nuclear Medicine (2017)

   Fulltext@MSK | Save
2. Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH

   Journal Article

   Tala, H.; Robbins, R.; Fagin, J. A.; Larson, S. M.; Tuttle, R. M.
   Journal of Clinical Endocrinology and Metabolism (2011)

   Fulltext@MSK | Save
3. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system

   Journal Article

   Tuttle, R. M.; Tala, H.; Shah, J.; Leboeuf, R.; Ghossein, R.; Gonen, M.; Brokhin, M.; Omry, G.; Fagin, J. A.; Shaha, A.
   Thyroid (2010)

   Fulltext@MSK | Save